Does ADALIMUMAB Cause Excessive granulation tissue? 38 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Excessive granulation tissue have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
38
Reports of Excessive granulation tissue with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
0
Deaths
20
Hospitalizations
How Dangerous Is Excessive granulation tissue From ADALIMUMAB?
Of the 38 reports, 20 (52.6%) required hospitalization, and 2 (5.3%) were considered life-threatening.
Is Excessive granulation tissue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Excessive granulation tissue?
CARBIDOPA\LEVODOPA (117)
BACLOFEN (31)
ZOLEDRONIC ACID (29)
ZOMETA (27)
AREDIA (21)
METHOTREXATE (19)
RITUXIMAB (13)
BECAPLERMIN (11)
PAMIDRONATE (11)
PREDNISONE (11)
Which ADALIMUMAB Alternatives Have Lower Excessive granulation tissue Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB